← Back to Search

Other

QPX2014 for Bacterial Infection

Phase 1
Waitlist Available
Research Sponsored by Qpex Biopharma, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 21 days
Awards & highlights

Study Summary

This trial is testing the safety and efficacy of QPX7728 in participants with bacterial infections.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 21 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 21 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Area under the plasma concentration versus time curve (AUC) between cohorts (single, multiple and combination dose)
Incidence of Treatment -Emergent Adverse events (AEs) by subject and by cohort (single, multiple and combination dose)
Number of patients with changes from baseline in safety parameters (single, multiple and combination dose)
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: QPX7728Experimental Treatment1 Intervention
antibiotic
Group II: QPX2014Experimental Treatment1 Intervention
antibiotic
Group III: PlaceboPlacebo Group1 Intervention
Matched placebo
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
QPX2014
2021
Completed Phase 1
~100
QPX7728
2021
Completed Phase 1
~100

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Qpex Biopharma, Inc.Lead Sponsor
6 Previous Clinical Trials
335 Total Patients Enrolled
Biomedical Advanced Research and Development AuthorityFED
82 Previous Clinical Trials
909,675 Total Patients Enrolled
Jeffery S Loutit, MBChBStudy DirectorQpex Biopharma, Inc.
2 Previous Clinical Trials
144 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHV
2020. "P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHV". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04380207.
~19 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top